Inventor · disambiguated record
Stefano V. Gulla
Also filed as: GULLA STEFANO · GULLA STEFANO V · GULLA STEFANO VINCENZO
10 granted patents·8 pending applications·5 citations·filing 2017–2024
81Inventor score
Files withPFIZER6ABCURO INC5BRIGHAM & WOMENS HOSPITAL INC2THE BRIGHAM AND WOMENS HOSPITAL2GAO HULIAN1
Top patents by PatentIndex Score
18 records- 0184US11339222B2KLRG1 antagonist signaling therapyTHE BRIGHAM AND WOMENS HOSPITAL·Filed 2017·Granted May 24, 2022·2 cites·41 claims
- 0281US10829553B2Interferon beta antibodies and uses thereofPFIZER·Filed 2017·Granted Nov 10, 2020·2 cites·17 claims
- 0378US12448439B2Interferon beta antibodies and uses thereofPFIZER·Filed 2023·Granted Oct 21, 2025·0 cites·9 claims
- 0478US11180561B2Killer cell lectin-like receptor subfamily G member 1 (KLRG1) depleting antibodiesABCURO INC·Filed 2020·Granted Nov 23, 2021·1 cites·23 claims
- 0576US2025101114A1Methods of treating disorders associated with excess or unwanted killer cell lectin-like receptor subfamily g member 1 (klrg1) expressing t cells with klrg1 depleting antibodiesABCURO INC·Filed 2024·Application pending·0 cites
- 0667US12139541B2Methods of treating disorders associated with excess or unwanted killer cell lectin-like receptor subfamily g member 1 (KLRG1) expressing t cells with KLRG1 depleting antibodiesABCURO INC·Filed 2021·Granted Nov 12, 2024·0 cites·19 claims
- 0765US11858986B2Interferon beta antibodies and uses thereofPFIZER·Filed 2020·Granted Jan 2, 2024·0 cites·18 claims
- 0863US11970524B2Recombinant ROBO2 proteins, compositions, methods and uses thereofPFIZER·Filed 2020·Granted Apr 30, 2024·0 cites·25 claims
- 0962US2024424133A1mRNA THERAPY WITH REDUCED IMMUNE REACTOGENICITYRVAC MEDICINES US INC·Filed 2024·Application pending·0 cites
- 1059US10906955B2Recombinant ROBO2 proteins, compositions, methods and uses thereofPFIZER·Filed 2018·Granted Feb 2, 2021·0 cites·48 claims
- 1159US2019085083A1Klrg1 signaling therapyTHE BRIGHAM AND WOMENS HOSPITAL·Filed 2018·Application pending·0 cites
- 1255US2025101112A1Killer cell lectin-like receptor subfamily g member 1 (klrg1) depleting antibodiesABCURO INC·Filed 2022·Application pending·0 cites
- 1354US2024174754A1Anti-klrg1 antibodiesABCURO INC·Filed 2022·Application pending·0 cites
- 1453US2024376225A1Cd21 antibodies and uses thereofGAO HULIAN·Filed 2022·Application pending·0 cites
- 1552US2025101107A1Cd8-targeted il-12 fusion proteinsREPERTOIRE IMMUNE MEDICINES INC·Filed 2023·Application pending·0 cites
- 1651US12365735B2Anti-KLRG1 antibodiesBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Granted Jul 22, 2025·0 cites·16 claims
- 1744US11365253B2Anti-ROBO2 antibodies, compositions, methods and uses thereofPFIZER·Filed 2018·Granted Jun 21, 2022·0 cites·22 claims
- 1841US2019194333A1Klrg1 depletion therapyBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefano V. Gulla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →